TY - JOUR
T1 - Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants
AU - Redding, Spencer W.
AU - Montgomery, Michael T.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1989/6
Y1 - 1989/6
N2 - Reactivation of herpes simplex virus (HSV) appears to play a significant role in oral mucositis resulting from bone marrow transplantation. The acyclic guanosine derivative acyclovir has been shown to be effective in treating and protecting against HSV infection in this group. The purpose of this study was to determine the role of HSV reactivation in oral mucositis in patients undergoing bone marrow transplantation who were seronegative for HSV or who received acyclovir prophylaxis. The results suggest that HSV plays an insignificant role in oral mucositis in these patients.
AB - Reactivation of herpes simplex virus (HSV) appears to play a significant role in oral mucositis resulting from bone marrow transplantation. The acyclic guanosine derivative acyclovir has been shown to be effective in treating and protecting against HSV infection in this group. The purpose of this study was to determine the role of HSV reactivation in oral mucositis in patients undergoing bone marrow transplantation who were seronegative for HSV or who received acyclovir prophylaxis. The results suggest that HSV plays an insignificant role in oral mucositis in these patients.
UR - http://www.scopus.com/inward/record.url?scp=0024339801&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024339801&partnerID=8YFLogxK
U2 - 10.1016/0030-4220(89)90008-X
DO - 10.1016/0030-4220(89)90008-X
M3 - Article
C2 - 2544843
AN - SCOPUS:0024339801
VL - 67
SP - 680
EP - 683
JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
SN - 2212-4403
IS - 6
ER -